ID
14467
Description
Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT00003963
Link
https://clinicaltrials.gov/show/NCT00003963
Keywords
Versions (1)
- 4/17/16 4/17/16 -
Uploaded on
April 17, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lymphoma NCT00003963
Eligibility Lymphoma NCT00003963
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Organ function
Data type
boolean
Alias
- UMLS CUI [1]
- C0201976
- UMLS CUI [2]
- C0201836
- UMLS CUI [3]
- C0201899
- UMLS CUI [4]
- C0201916
Description
Gynaecological status
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
Myelodysplastic syndrome
Data type
boolean
Alias
- UMLS CUI [1]
- C3463824
Description
CNS disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0007682
Description
Infection
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
Vinorelbine and rituxan
Data type
boolean
Alias
- UMLS CUI [1]
- C0078257
- UMLS CUI [2]
- C0732355
Similar models
Eligibility Lymphoma NCT00003963
- StudyEvent: Eligibility
C0277556 (UMLS CUI [2])
C1328050 (UMLS CUI [3])
C1831743 (UMLS CUI [4])
C2242529 (UMLS CUI [5])
C0005961 (UMLS CUI [6])
C0032181 (UMLS CUI [2])
C0201836 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201916 (UMLS CUI [4])
C0006147 (UMLS CUI [2])
C0732355 (UMLS CUI [2])